Repligen Corp.

Repligen Corp., founded in 1981, supplies bioprocessing technologies—Protein A ligands, chromatography and filtration systems, and process analytics—to biopharmaceuticals, diagnostics, and CMOs worldwide.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Medical Equipment Manufacturing

Employees: 1,778
HQ: Waltham

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
RGEN	Repligen Corp. Cap: 9.4B \| P/E: 8341.0	EQUITY	NMS	USD	US7599161095	Active	📈